RXO Inc (NYSE: RXO) closed the day trading at $20.21 down -2.37% from the previous closing price of $20.70. In other words, the price has decreased by -$0.49 from its previous closing price. On the day, 537527 shares were traded. RXO stock price reached its highest trading level at $20.60 during the session, while it also had its lowest trading level at $20.00.
Ratios:
For a better understanding of RXO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 473.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 94.61. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 0.94 whereas as Long-Term Debt/Eq ratio is at 0.85.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on February 09, 2024, Reiterated its Market Perform rating but revised its target price to $19.50 from $16.50 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 09 ’24 when MFN Partners, LP bought 913,186 shares for $20.29 per share. The transaction valued at 18,528,544 led to the insider holds 15,588,555 shares of the business.
MFN Partners, LP bought 919,720 shares of RXO for $19,350,909 on Feb 08 ’24. The 10% Owner now owns 14,675,369 shares after completing the transaction at $21.04 per share. On Feb 02 ’24, another insider, MFN Partners, LP, who serves as the 10% Owner of the company, bought 747,424 shares for $20.25 each. As a result, the insider paid 15,135,336 and bolstered with 13,755,649 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2.37B and an Enterprise Value of 2.92B. As of this moment, RXO’s Price-to-Earnings (P/E) ratio for their current fiscal year is 606.91, and their Forward P/E ratio for the next fiscal year is 29.90. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.60 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 0.74 whereas that against EBITDA is 28.34.
Stock Price History:
Over the past 52 weeks, RXO has reached a high of $24.33, while it has fallen to a 52-week low of $16.94. The 50-Day Moving Average of the stock is 21.58, while the 200-Day Moving Average is calculated to be 20.58.
Shares Statistics:
Over the past 3-months, RXO traded about 648.18K shares per day on average, while over the past 10 days, RXO traded about 435.72k shares per day. A total of 117.03M shares are outstanding, with a floating share count of 114.68M. Insiders hold about 2.00% of the company’s shares, while institutions hold 98.68% stake in the company. Shares short for RXO as of Feb 29, 2024 were 2.75M with a Short Ratio of 4.24, compared to 2.52M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.34% and a Short% of Float of 4.64%.
Earnings Estimates
Current recommendations for the stock of the company come from 14 analysts. On average, analysts expect EPS of -$0.03 for the current quarter, with a high estimate of $0 and a low estimate of -$0.06, while EPS last year was $0.11. The consensus estimate for the next quarter is $0.03, with high estimates of $0.07 and low estimates of -$0.01.
Analysts are recommending an EPS of between $0.42 and $0.1 for the fiscal current year, implying an average EPS of $0.24. EPS for the following year is $0.69, with 15 analysts recommending between $0.82 and $0.5.
Revenue Estimates
11 analysts predict $932.52M in revenue for the current quarter. It ranges from a high estimate of $979.9M to a low estimate of $870.66M. As of the current estimate, RXO Inc’s year-ago sales were $1.01B, an estimated decrease of -7.70% from the year-ago figure. For the next quarter, 11 analysts are estimating revenue of $971.02M, an increase of 0.80% over than the figure of -$7.70% in the same quarter last year. There is a high estimate of $1.03B for the next quarter, whereas the lowest estimate is $915M.
A total of 13 analysts have provided revenue estimates for RXO’s current fiscal year. The highest revenue estimate was $4.26B, while the lowest revenue estimate was $3.84B, resulting in an average revenue estimate of $4.03B. In the same quarter a year ago, actual revenue was $3.93B, up 2.70% from the average estimate. Based on 13 analysts’ estimates, the company’s revenue will be $4.47B in the next fiscal year. The high estimate is $5.02B and the low estimate is $4.11B. The average revenue growth estimate for next year is up 10.80% from the average revenue estimate for this year.
